Figure 1.
Efficacy outcome in lipid content of plaques between the two groups of treatment.
Notes: Group A patients were treated with Cardioaspirin® and Aterofisiol®. Group B patients were treated with Cardioaspirin® and a placebo.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.